Cardiovascular Pathophysiology & Therapeutics (CardioPath) is an International PhD program focused on the study of pathophysiology, molecular mechanisms and development of novel therapies for cardiovascular diseases. The program has been established in 2015 through the Agreement among 2 Universities:
and one International Research Center:
The training program lasts 3 years and the PhD students are required to achieve 180 ECTS (or CFU) to be admitted to the final exam (60 ECTS/year).
CardioPath is a program of excellence:
a) The Academic Council is composed by outstanding members highly recognized for their contribute to science and dedication to teaching and knowledge transfer;
b) The international platform of the program makes possible overcome the limitations in resources and logistics present at the national level;
c) The availability of expertise in different scientific fields and a variety of teaching methods offered by the Research Doctorate Network make possible broaden the spectrum of the scientific projects to be realized by the PhD candidates.
The main areas of interest of the PhD program are:
• Heart failure, cardiomyopathies and arrhythmogenesis
• Coronary artery disease (CAD) and peripheral artery disease (PAD)
• Arterial hypertension and preventive cardiology
• Non-invasive imaging diagnostics of cardio-vascular disease
• Interventional cardiology.
At the end of the course PhD scholars are expected:
a) to be familiar with research tools (from bench to bedside)
b) to be able to conceive, design and perform a clinical and/or basic-science research project
d) to be able to further extend the available knowledge to improve current diagnostic and therapeutic protocols to cardiovascular diseases and to propose innovative approaches.
For this purpose, the training course is based on the following scheme:
1) didactic training to provide the cultural foundations necessary for the research activities,
2) experimental work in the laboratory or in a clinical setting under the supervision of a Tutor,
3) training rotations in the partner institutions.